4-(2-(4,5-DIHYDRO-3-METHYL-5-OXO-1-PHENYL-1H-PYRAZOL-4-YL)DIAZENYL)-N-(5-METHYL-1,3,4-THIADIAZOL-2-YL)BENZENESULFONAMIDE
UNII NB136DZU0E
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1h-pyrazol-4-yl)diazenyl)-n-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NB136DZU0E.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 29822-02-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H17N7O3S2 QUQSVWJCEVPOIZ-QURGRASLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1h-pyrazol-4-yl)diazenyl)-n-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.